ISL
Ingalls & Snyder LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
4,056
-100
| -2% | -$8.28K | 0.01% | 342 |
|
|
2025
Q1 | $337K | Sell |
4,156
-215
| -5% | -$17.4K | 0.01% | 331 |
|
|
2024
Q4 | $394K | Sell |
4,371
-603
| -12% | -$54.4K | 0.02% | 313 |
|
|
2024
Q3 | $491K | Hold |
4,974
| – | – | 0.02% | 290 |
|
|
2024
Q2 | $461K | Sell |
4,974
-55
| -1% | -$5.1K | 0.02% | 285 |
|
|
2024
Q1 | $477K | Sell |
5,029
-100
| -2% | -$9.49K | 0.02% | 284 |
|
|
2023
Q4 | $458K | Sell |
5,129
-835
| -14% | -$74.6K | 0.02% | 284 |
|
|
2023
Q3 | $435K | Sell |
5,964
-555
| -9% | -$40.5K | 0.02% | 285 |
|
|
2023
Q2 | $542K | Sell |
6,519
-30
| -0.5% | -$2.49K | 0.03% | 274 |
|
|
2023
Q1 | $499K | Sell |
6,549
-500
| -7% | -$38.1K | 0.03% | 278 |
|
|
2022
Q4 | $585K | Sell |
7,049
-3,048
| -30% | -$253K | 0.03% | 248 |
|
|
2022
Q3 | $801K | Sell |
10,097
-67
| -0.7% | -$5.32K | 0.04% | 211 |
|
|
2022
Q2 | $755K | Sell |
10,164
-720
| -7% | -$53.5K | 0.04% | 224 |
|
|
2022
Q1 | $978K | Sell |
10,884
-2,330
| -18% | -$209K | 0.04% | 220 |
|
|
2021
Q4 | $1.48M | Sell |
13,214
-50
| -0.4% | -$5.6K | 0.07% | 179 |
|
|
2021
Q3 | $1.67M | Sell |
13,264
-473
| -3% | -$59.4K | 0.08% | 178 |
|
|
2021
Q2 | $1.86M | Sell |
13,737
-1,723
| -11% | -$233K | 0.08% | 171 |
|
|
2021
Q1 | $2.1M | Sell |
15,460
-67
| -0.4% | -$9.09K | 0.1% | 154 |
|
|
2020
Q4 | $2.19M | Sell |
15,527
-1,942
| -11% | -$273K | 0.11% | 145 |
|
|
2020
Q3 | $1.95M | Buy |
17,469
+14,969
| +599% | +$1.67M | 0.13% | 121 |
|
|
2020
Q2 | $280K | Buy |
+2,500
| New | +$280K | 0.02% | 314 |
|